Fareeha Siddiqui - Biotricity Senior Solutions
Executive
Fareeha Siddiqui is Senior Solutions of Biotricity
| Phone | (800) 590-4155 |
| Web | https://www.biotricity.com |
Biotricity Management Efficiency
The company has return on total asset (ROA) of (0.8862) % which means that it has lost $0.8862 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (41.0079) %, meaning that it created substantial loss on money invested by shareholders. Biotricity's management efficiency ratios could be used to measure how well Biotricity manages its routine affairs as well as how well it operates its assets and liabilities.Biotricity currently holds 23.88 M in liabilities with Debt to Equity (D/E) ratio of 6.45, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Biotricity has a current ratio of 1.51, which is within standard range for the sector. Debt can assist Biotricity until it has trouble settling it off, either with new capital or with free cash flow. So, Biotricity's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biotricity sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biotricity to invest in growth at high rates of return. When we think about Biotricity's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Taylor Ocasio | Tela Bio | N/A | |
| Paul Pignato | CVRx Inc | N/A | |
| Jacqueline Keller | Clearpoint Neuro | N/A | |
| Corey Hancock | Nortech Systems Incorporated | N/A | |
| Sandra CPA | Delcath Systems | 45 | |
| Johnny MD | Delcath Systems | 60 | |
| Les DeLuca | Bluejay Diagnostics | N/A | |
| Robert John | CVRx Inc | N/A | |
| Jennifer Armstrong | Tela Bio | 55 | |
| Thomas Ross | MaxCyte | 64 | |
| Deina Walsh | Bone Biologics Corp | 60 | |
| John Lindeen | Nortech Systems Incorporated | 60 | |
| Jeremy Stigall | Clearpoint Neuro | 41 | |
| Michael Leonard | Tela Bio | N/A | |
| Michael Soule | Movano Inc | N/A | |
| Jonelle Burnham | CVRx Inc | 54 | |
| Indranil Dey | Bluejay Diagnostics | 62 | |
| Jennifer Englund | CVRx Inc | N/A | |
| Jay Gelfman | MaxCyte | N/A | |
| Ronald CPA | MaxCyte | 67 | |
| Tonya SPHR | CVRx Inc | 52 | |
Management Performance
| Return On Equity | -41.01 | ||||
| Return On Asset | -0.89 |
Biotricity Leadership Team
Elected by the shareholders, the Biotricity's board of directors comprises two types of representatives: Biotricity inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biotricity. The board's role is to monitor Biotricity's management team and ensure that shareholders' interests are well served. Biotricity's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biotricity's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Fareeha Siddiqui, Senior Solutions | ||
| Amjad Talpur, Senior Operations | ||
| George Nikopoulos, Director Development | ||
| Waqaas AlSiddiq, Founder, Chairman, CEO and Executive Officer | ||
| Amir Ali, Chief Officer | ||
| John Ayanoglou, Chief Officer | ||
| Andy Wong, Vice Operations | ||
| Matt Zabel, Vice Strategy |
Biotricity Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Biotricity a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -41.01 | ||||
| Return On Asset | -0.89 | ||||
| Profit Margin | (1.17) % | ||||
| Operating Margin | (0.96) % | ||||
| Current Valuation | 38.87 M | ||||
| Shares Outstanding | 21.48 M | ||||
| Shares Owned By Insiders | 48.61 % | ||||
| Shares Owned By Institutions | 1.62 % | ||||
| Number Of Shares Shorted | 459.95 K | ||||
| Price To Earning | (6.70) X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Biotricity information on this page should be used as a complementary analysis to other Biotricity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Biotricity OTC Stock
If you are still planning to invest in Biotricity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biotricity's history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |